Grace Century brings the future of healthcare to smart investors worldwide

Grace Century, a private equity firm based in the United Arab Emirates, talks about why it selected Provia Labs as a game-changing opportunity for international investors. According to Scott Wolf, Director of Research for Grace Century, "Researchers from around the world continue to explore potential therapies using adult stem cells such as those found in bone marrow, umbilical cord blood, and now teeth. While they explore and develop these therapies, over 30 million children in the US alone are losing teeth and unknowingly destroying these valuable stem cells each year. These stem cells can be banked for future use if properly collected, transported, tested, processed, and preserved. This opportunity is the basis of Provia Laboratories' core business – Store-A-Tooth™."

Grace Century, an international Research and Private Equity Company based out of Ras Al Khaimah, United Arab Emirates, is an expert at providing game-changing opportunities to investors worldwide. Only potential business models are accepted for consideration. The industries Grace Century focuses on are Healthcare, including life sciences, financial services and alternative or renewable energies. Grace differs from a typical private equity firm, in that, once it has researched a niche industry, it selects only the most promising "young" firm within that industry, conducts it's own stringent due diligence, and then negotiates for both its group and Grace, the best capital formation package it can. Scott Wolf, Director of Research for Grace says: "Our latest project is in the newly discovered harvesting of "stem cells from children's Milk Teeth". Cryogenically banking these teeth and their cells offers parents an alternative years after birth to the "Cord Blood banking" finding. Cord Blood provides stem cells harvested from a baby's umbilical cord and are far less potent that stem cells from Dental Pulp. Stems cells from Dental pulp are shown to potentially regrow bone, muscle and tissue for trea™ent in diseases such as Alzheimer's, Diabetes and spinal-cord injuries. One day, it may even be possible to re-grow organs. This is the future of medicine." He adds, "Stem cells have created a new industry in bio-banking. This newly discovered source of stem cells is far less intrusive for collection rather than alternatives such as bone marrow collection or surgeries." Finally: "Therapies are being developed globally at firms, hospitals and virtually every university. It will be years before science catches up. We know that the stem cells are the key and it is important to unlock that door now. When parents have cryogenically stored their children's milk teeth and its cells, they will be ready for the future. This is the only way we have found for our members to make money in this untapped field now." Grace has aligned itself with who they identify as the industry leader, Provia Labs and it's branded "Store-a-tooth". Through its network, Grace has assisted Provia Labs in a Joint Venture in Asia, where Provia will have a minority stake in a Dental Stem cell bank. Efforts are in its infancy for a similar model in Canada and the Middle East. Provia has its own operations already established in the United States. Researchers from around the world continue to explore potential therapies using adult stem cells such as those found in bone marrow, umbilical cord blood, and now teeth. While they explore and develop these therapies, over 30 million children in the US alone are losing teeth and unknowingly destroying these valuable stem cells each year. These stem cells can be banked for future use if properly collected, transported, tested, processed, and preserved. This opportunity is the basis of Provia Laboratories core business - Store-A-Tooth™. Member Testimonial: Eddie Leong, a Grace Century member in Singapore - Eddie Leong, a Grace Century member in Singapore, stated: "Grace Century provides excellent services and is in close communications with the top management of the inves™ents. I have invested as a result of their research and am pleased to endorse them." Eddie Leong added: "Since the discovery a decade ago in USA, discoveries in dental stem cell usage have moved forward rapidly. This provides much potential for regenerative medicine and is another new industry that is taking off. Provia Laboratories is the leading bio-banking service provider recognized by the US health authorities and leading Universities. They are already expanding in USA and abroad. It is expected that given the modest storage costs, the industry will take off in a big way in coming years." About Provia Laboratories LLC Provia Laboratories, LLC (www.provialabs.com) is a healthcare services company specializing in high quality biobanking (preservation of biological specimens). The company's Store-A-Tooth™ service platform enables the collection, transport, processing, and storage of dental stem cells for potential use in future stem-cell therapies. The company advises industrial, academic, and governmental clients on matters related to the preservation of biological specimens for research and clinical use. In addition, Provia offers a variety of products for use in complex biobanking environments to improve sample logistics, security, and quality. Provia Labs is a member of ISBER, the International Society for Biological and Environmental Repositories.